SEC Form 5 · accession 0001570523-18-000005
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Dec 31, 2017
Accepted (ET)
Mar 28, 2018 · 7:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Apr 13, 2017 | P | 1,000 | $0.05 | A | 22,059,859 | D | |
| Common stock | Apr 13, 2017 | P | 1,000 | $0.05 | A | 22,059,859 | D | |
| Common stock | Apr 13, 2017 | P | 5,000 | $0.05 | A | 22,059,859 | D | |
| Common stock | Apr 19, 2017 | P | 1,000 | $0.05 | A | 22,059,859 | D | |
| Common stock | Apr 19, 2017 | P | 1,000 | $0.06 | A | 22,059,859 | D | |
| Common stock | May 3, 2017 | P | 11,000 | $0.06 | A | 22,059,859 | D | |
| Common stock | May 3, 2017 | P | 2,000 | $0.07 | A | 22,059,859 | D | |
| Common stock | May 3, 2017 | P | 1,700 | $0.07 | A | 22,059,859 | D | |
| Common stock | May 22, 2017 | P | 1,250 | $0.07 | A | 22,059,859 | D | |
| Common stock | May 22, 2017 | P | 15,050 | $0.07 | A | 22,059,859 | D | |
| Common stock | May 22, 2017 | P | 9,079 | $0.07 | A | 22,059,859 | D | |
| Common stock | May 22, 2017 | P | 1,250 | $0.07 | A | 22,059,859 | D | |
| Common stock | May 22, 2017 | P | 1,250 | $0.07 | A | 22,059,859 | D | |
| Common stock | May 22, 2017 | P | 1,250 | $0.07 | A | 22,059,859 | D | |
| Common stock | May 22, 2017 | P | 1,250 | $0.07 | A | 22,059,859 | D | |
| Common stock | May 22, 2017 | P | 1,250 | $0.07 | A | 22,059,859 | D | |
| Common stock | May 22, 2017 | P | 1,250 | $0.07 | A | 22,059,859 | D | |
| Common stock | May 22, 2017 | P | 28,000 | $0.07 | A | 22,059,859 | D | |
| Common stock | May 22, 2017 | P | 39,121 | $0.07 | A | 22,059,859 | D | |
| Common stock | Jul 6, 2017 | P | 1,000 | $0.05 | A | 22,059,859 | D | |
| Common stock | Jul 11, 2017 | P | 2,000 | $0.06 | A | 22,059,859 | D | |
| Common stock | Aug 23, 2017 | P | 10,000 | $0.04 | A | 22,059,859 | D | |
| Common stock | Aug 23, 2017 | P | 2,000 | $0.04 | A | 22,059,859 | D | |
| Common stock | Aug 24, 2017 | P | 5,000 | $0.04 | A | 22,059,859 | D | |
| Common stock | Aug 24, 2017 | P | 1,000 | $0.05 | A | 22,059,859 | D | |
| Common stock | Aug 24, 2017 | P | 1,000 | $0.05 | A | 22,059,859 | D | |
| Common stock | Aug 25, 2017 | P | 2,000 | $0.04 | A | 22,059,859 | D | |
| Common stock | Aug 29, 2017 | P | 1,000 | $0.04 | A | 22,059,859 | D | |
| Common stock | Sep 1, 2017 | P | 2,000 | $0.04 | A | 22,059,859 | D | |
| Common stock | Sep 12, 2017 | P | 1,000 | $0.03 | A | 22,059,859 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This is part 3 of 16 submissions.